cas 51047-56-4|| where to buy 3-Piperazin-1-yl-pyridazine

Nombre del producto:3-Piperazin-1-yl-pyridazine

IUPAC Name:3-(piperazin-1-yl)pyridazine

Unidad de embalaje	Stock disponible	Precio($)
CM102211-100mg	in stock	ţǭ
CM102211-250mg	in stock	ĜƩǎ
CM102211-1g	in stock	ǭţř
CM102211-5g	in stock	Žřǎ

Sólo para uso en I+D..

Formulario de consulta

Nombre químico

Número CAS

Cantidad*

Especificaciones requeridas*
(% de ensayo, grado de material, etc.)

Nombre de contacto*

Correo electrónico de contacto*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 51047-56-4 regularly via the above email.

Notas adicionales

Verification code*

refresh

: Núm. De CAS :51047-56-4; Fórmula molecular:C8H12N4; Punto de fusión:-; Código de sonrisas:N1(CCNCC1)C2=CC=CN=N2; Densidad:

: Número de catálogo:CM102211; Peso molecular:164.21; Punto de ebullición:381.1±22.0°C; Nº Mdl:MFCD01563781; Almacenamiento:Store at 2-8°C.

: Pyridazines; Pyridazine, also known as o-diazobenzene, is a six-membered heterocyclic compound containing two nitrogen heteroatoms in the 1 and 2 positions with a special structure and a wide biological activity. Pyridazine is more and more popular in drug development, and a variety of pyridazine drugs have been developed and marketed. From the perspective of the therapeutic field, pyridazine drug molecules are mainly used for tumor treatment, but also involve in many therapeutic fields such as inflammation, hypertension and cardiovascular disease. With the increase and in-depth of research, pyridazine drugs will play more roles in the treatment of diseases.

: Piperazines; Piperazine is an organic compound consisting of a six-membered ring containing two nitrogen atoms in opposite positions in the ring. The chemical formula of piperazine is C4H10N2, and it is an important pharmaceutical intermediate. Pyrimidines and piperazines are known to be the backbone of many bulk compounds and important core structures for approved drugs; studies have shown that combining a pyridine ring with a piperazine moiety within a single structural framework enhances biological activity.